Division of Risk Management and Audit Liaison (RMAL)
The Division of Risk Management and Audit Liaison directs and oversees the management control function, including oversight for all NIH components and activities of potential concern under the Federal Manager's Financial Integrity Act; assures that satisfactory action is taken to review activities required to improve NIH's ability to adequately and reasonably control its resources; directs or provides support to task forces and study groups addressing organization and management initiatives and issues; directs and oversees the NIH Risk Management program; provides for the central coordination of all OIG/GAO reviews (except for OIG criminal investigations); and conducts audit follow-up activities for reviews conducted by the OIG and GAO.
- NIH Manual Chapter 1750 Policy
Outlines responsibilities for complying with the NIH Risk Management Program. The Risk Management Program establishes and outlines procedures for managing risks and for evaluating controls that improve programs and operations within the agency's extramural, intramural, and administrative components.
- NIH Manual Chapter 1752 Policy
Outlines responsibilities for assisting with Office of Inspector General (OIG), or Government Accountability Office (GAO) program audit reviews conducted at NIH and for responding to, and taking corrective action on OIG or GAO program audit findings and recommendations.